Weill Cornell Among Centers Participating in Myelodysplastic Syndrome Research ConsortiumPosted: June 12, 2012 Filed under: Leukemia News | Tags: Myelodysplastic Syndrome, Weill Cornell Leukemia Program Leave a comment
Six academic medical centers, including Weill Cornell Medical College, have set up the first privately funded consortium in the US to focus on clinical trials and research for patients with myelodysplastic syndrome (MDS).
The MDS Clinical Research Consortium is a five-year, $16 million initiative sponsored by the Aplastic Anemia & MDS International Foundation and supported by the Edward P Evans Foundation.
By joining forces, the centers hope to achieve a ‘critical mass’ of dedicated institutions that can support the evaluation of promising new MDS therapies as well as epidemiological and translational studies leading to new treatments and classifications for the disease.
The participating centers are Weill Cornell Medical College, Taussig Cancer Institute at Cleveland Clinic; Dana Farber Cancer Institute; MD Anderson Cancer Center; H Lee Moffitt Cancer Center and Research Institute, and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.